News Sentiment

PHAT sentiment intelligence

Phathom Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 71 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 12.61 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 62

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+12.6% over one week, +21.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Form 4 Phathom Pharmaceuticals Inc For: 16 July By Investing.com

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 12.6% Price confirming higher
Trend fit Trend inactive 21.6% over four weeks
Fair value 18.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 38
Negative 13

Relevance

Why the article matched

Direct first
Direct company coverage 62
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 6
GlobeNewswire 6
TradingKey 5
TradingView 5
simplywall.st 5
Investing.com 4
Stock Traders Daily 3

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 27
Analyst action 6
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 71
Finviz Direct company coverage

PHAT - Phathom Pharmaceuticals Inc Stock Price and Quote

This article provides comprehensive stock information for Phathom Pharmaceuticals Inc (PHAT), including its current price, market capitalization, financial metrics, and recent news. It also lists analyst ratings and insider trading activities, offering a detailed overview of the

Tone
Positive 60/100
Event
Analyst action
Published
01 Jun 2026 04:11
Source
Finviz
Pluang Direct company coverage

Phathom Pharmaceuticals shows negative capital efficiency, destroying value amid high R&D costs.

Phathom Pharmaceuticals currently exhibits a negative Return on Invested Capital (ROIC) of -53.45%, significantly below its Weighted Average Cost of Capital (WACC) of 15.49%, indicating it is destroying shareholder value. This is typical for clinical-stage biopharmaceutical compa

Tone
Neutral 50/100
Event
Market update
Published
28 May 2026 20:40
Source
Pluang
Stock Titan Direct company coverage

[Form 4] Phathom Pharmaceuticals, Inc. Insider Trading Activity

Phathom Pharmaceuticals director Asit Parikh reported gifting 56,000 shares of common stock on May 22, 2026. These transfers were bona fide gifts to a trust benefiting his spouse and were not market trades. The transactions reflect estate or family planning rather than buying or

Tone
Neutral 50/100
Event
Market update
Published
27 May 2026 20:10
Source
Stock Titan
Stock Traders Daily Direct company coverage

How (PHAT) Movements Inform Risk Allocation Models

This article analyzes Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) using AI models, highlighting weak near-term sentiment but potential long-term strength. It outlines various trading strategies—position, momentum, and risk hedging—and provides multi-timeframe signal analysis with

Tone
Positive 71/100
Event
Market update
Published
26 May 2026 04:34
Source
Stock Traders Daily
Stock Titan Direct company coverage

PHAT SEC Filings - Phathom Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms

This page provides a comprehensive overview of Phathom Pharmaceuticals (PHAT) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, and 8-K material event disclosures. It details recent insider transactions, changes in beneficial ownership by various investment gro

Tone
Neutral 50/100
Event
Earnings
Published
24 May 2026 13:09
Source
Stock Titan